Metabolic Imaging of Head and Neck Cancer Organoids

Optical metabolic imaging quantifies heterogeneous cell populations

(2015) Alex J. Walsh et al.   Biomedical Optics Express

In Vivo Autofluorescence Imaging of Tumor Heterogeneity in Response to Treatment

(2015) Amy T. Shah et al.   NEOPLASIA

Organoid cultures for the analysis of cancer phenotypes

(2014) Norman Sachs et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Optical Metabolic Imaging of Treatment Response in Human Head and Neck Squamous Cell Carcinoma

(2014) Amy T. Shah et al.   PLoS One

Optical Metabolic Imaging Identifies Glycolytic Levels, Subtypes, and Early-Treatment Response in Breast Cancer

(2013) A. J. Walsh et al.   CANCER RESEARCH

In vitro three-dimensional (3D) models in cancer research: An update

(2011) Lauren C. Kimlin et al.   MOLECULAR CARCINOGENESIS

Principles of early drug discovery

(2010) JP Hughes et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Epidermal Growth Factor Receptor Antibody Cetuximab Induces Autophagy in Cancer Cells by Downregulating HIF-1  and Bcl-2 and Activating the Beclin 1/hVps34 Complex

(2010) X. Li et al.   CANCER RESEARCH

Emerging drugs to treat squamous cell carcinomas of the head and neck

(2010) Christopher Fung et al.   EXPERT OPINION ON EMERGING DRUGS

Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse

(2010) Ira Skvortsova et al.   RADIOTHERAPY AND ONCOLOGY

Molecular therapy in head and neck oncology

(2009) Jacques Bernier et al.   Nature Reviews Clinical Oncology